Stocks
Zynerba Pharmaceuticals (ZYNE) EBITDA margin US GAAP (year values) |
|||||||||
| 2014 | 2015 | 2016 | 2017 | 2018 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -696.4% | -4 481% | -321 941% | -46 974% | ||||
| Changes by years, y/y, % | -634pp | -3 785pp | -317 460pp | +321 941pp | +276.6% | ||||
Zynerba Pharmaceuticals. EBITDA margin, %
Zynerba Pharmaceuticals. EBITDA margin, changes, pp
Zynerba Pharmaceuticals (ZYNE) EBITDA margin US GAAP (quarter values) |
||||||||
| 2017Q4 | 2018Q1 | 2018Q2 | 2018Q3 | 2018Q4 | LTM ? | |||
| EBITDA margin, % | ? | -9 325% | ||||||
| Changes by years, y/y, % | ||||||||
| Changes by quarters, q/q, % | ||||||||
